Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Michael A. Becker

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Becker, Michael

Item TypeName
Concept Glucosephosphate Dehydrogenase
Concept Glutathione Reductase
Concept Glucosephosphate Dehydrogenase Deficiency
Concept Xanthine Oxidase
Concept Xanthine Dehydrogenase
Concept Urate Oxidase
Academic Article Update on emerging urate-lowering therapies.
Academic Article Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serum urate in healthy volunteers.
Academic Article Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics.
Academic Article Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase.
Academic Article Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
Academic Article Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout.
Academic Article Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials.
Academic Article Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study.
Academic Article Diabetes and gout: efficacy and safety of febuxostat and allopurinol.
Academic Article Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapy.
Academic Article Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy.
Academic Article Long-term management of gout: nonpharmacologic and pharmacologic therapies.
Academic Article Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout.
Academic Article Long-term safety of pegloticase in chronic gout refractory to conventional treatment.
Academic Article Genetic aspects of gout.
Academic Article Regulation of 5-phosphoribosyl-1-pyrophosphate synthesis in human fibroblasts by the concentration of inorganic phosphate.
Academic Article The phosphogluconate pathway and synthesis of 5-phosphoribosyl-1-pyrophosphate in human fibroblasts.

Search Criteria
  • Oxidoreductases